Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.Allogene Therapeutics (NASDAQ: ALLO ) has been on my watch list since May of 2020, when the company publicized data from their Phase I ALPHA study of ALLO-501 in relapsed/refractory non-Hodgkin lymphoma (NHL). That press release helpedBiologics is a full ...